Search research articles
Contact Us
Filters
Showing results (141-150 of 156) with videos related to
Page
of 16
Sort By:
Leukemia
|
June 9, 1999
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
E Archimbaud, U Jehn, X Thomas, et al.
Leukemia
|
January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group
P Stryckmans, T De Witte, J P Marie, et al.
Anti-Cancer Drugs
|
April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer
K Mattson, J Vansteenkiste, R Stupp, et al.
Transfusion
|
March 30, 2000
Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF
V Fraipont, B Sautois, E Baudoux, et al.
The Journal of Antimicrobial Chemotherapy
|
June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients
M Boogaerts, J Maertens, A van Hoof, et al.
Blood
|
January 1, 1996
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
O Hermine, C Haioun, E Lepage, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma
A Bosly, E Lepage, B Coiffier, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 26, 2001
Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patients
A M Langouët, P Brice, D Simon, et al.
Leukemia
|
September 19, 2008
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial
E Willems, F Baron, E Baudoux, et al.
Haematologica
|
April 6, 1999
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields
B Sautois, V Fraipont, E Baudoux, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 156) with videos related to
Sort By:
Page
of 16
Leukemia
|
June 9, 1999
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
E Archimbaud, U Jehn, X Thomas, et al.
Leukemia
|
January 1, 1992
Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group
P Stryckmans, T De Witte, J P Marie, et al.
Anti-Cancer Drugs
|
April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer
K Mattson, J Vansteenkiste, R Stupp, et al.
Transfusion
|
March 30, 2000
Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF
V Fraipont, B Sautois, E Baudoux, et al.
The Journal of Antimicrobial Chemotherapy
|
June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients
M Boogaerts, J Maertens, A van Hoof, et al.
Blood
|
January 1, 1996
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
O Hermine, C Haioun, E Lepage, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma
A Bosly, E Lepage, B Coiffier, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 26, 2001
Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patients
A M Langouët, P Brice, D Simon, et al.
Leukemia
|
September 19, 2008
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial
E Willems, F Baron, E Baudoux, et al.
Haematologica
|
April 6, 1999
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields
B Sautois, V Fraipont, E Baudoux, et al.
Page
of 16